Taka Koda
Private Equity Investor bei Remiges Ventures Inc.
Aktive Positionen von Taka Koda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Remiges Ventures Inc.
 Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Private Equity Investor | 01.07.2019 | - |
Digestome Therapeutics, Inc.
 Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Corporate Officer/Principal | 01.06.2017 | - |
Karriereverlauf von Taka Koda
Ehemalige bekannte Positionen von Taka Koda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Mitsui & Co. Global Investment, Inc.
 Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01.04.2012 | 01.03.2014 |
Mitsui & Co. Global Investment Ltd.
 Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Private Equity Investor | 01.04.2009 | 01.03.2012 |
| QD LASER, INC. | Corporate Officer/Principal | 01.01.2008 | 01.03.2009 |
| MITSUI & CO., LTD. | Corporate Officer/Principal | 01.04.2003 | 01.03.2007 |
Ausbildung von Taka Koda
| University of Tokyo | Undergraduate Degree |
| Hoshi University | Undergraduate Degree |
Statistik
International
| Japan | 7 |
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Private Equity Investor | 3 |
| Undergraduate Degree | 2 |
Sektoral
| Finance | 4 |
| Consumer Services | 3 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MITSUI & CO., LTD. | Process Industries |
| QD LASER, INC. | Electronic Technology |
| Private Unternehmen | 4 |
|---|---|
Mitsui & Co. Global Investment, Inc.
Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Finance |
Mitsui & Co. Global Investment Ltd.
Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Finance |
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Finance |
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Health Services |
